80 Recruiting Trials
Clinical Trials
for Diabetes in Pennsylvania
80 clinical trials for Diabetes are currently recruiting participants at study sites in Pennsylvania. Study-related care is provided at no cost.
80
Recruiting trials
76
Study sites
21
Cities
35
Industry-sponsored
13
Phase 2
25
Phase 3
Diabetes clinical trials in Pennsylvania: what to expect
Diabetes is one of the largest areas of clinical research, and the trials differ a great deal by type. Type 2 studies most often test new glucose-lowering or weight-reducing medicines, once-weekly insulins, and combinations with GLP-1 drugs, in people whose A1c is above goal on their current treatment. Type 1 studies test automated insulin delivery systems, immune therapies for people recently diagnosed or at high risk, and cell-based approaches. Others focus on the complications: kidney disease, eye disease, nerve pain and foot ulcers.
In Pennsylvania, recruiting diabetes studies are concentrated in Philadelphia, Pittsburgh, Uniontown and Beaver, with sites in 17 other cities. 35 of the 80 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.
Who diabetes trials usually look for
Type 2 trials typically ask for a confirmed diagnosis, an A1c in a stated range (often between 7 and 10.5 percent) and a stable dose of your current medicines for at least a few months. Many exclude recent insulin use, a recent heart attack or stroke, or kidney function below a cut-off. Type 1 trials are often limited by time since diagnosis and by age, and some enroll children and teenagers with a parent's consent.
You do not need to know your A1c or kidney numbers to ask about a trial; the site measures them at screening.
What taking part involves
Screening includes blood work and a review of your history. Medicine trials usually last six months to three years with visits every one to three months, and many provide a glucose monitor and supplies for the duration. Some compare a new drug with a standard one rather than a placebo, so everyone receives active treatment; others include a placebo arm, and the consent form says which. Study drugs, devices, visits and labs are provided at no cost, and most trials pay for time and travel.
Questions worth asking the study team
Whether you would stay on your current medicines; whether there is a placebo group; how often visits are and whether any can be done remotely; and whether your own doctor will receive the results of study labs. If you have type 1 diabetes, ask whether the study uses your own pump or monitor.
Showing 20 of 80 recruiting Diabetes trials in Pennsylvania
A Fruit and Vegetable Prescription Program
Recruiting
This trial is looking for people with type 2 diabetes who want to improve their diet. Participants will receive vouchers for fruits and vegetables and be contacted by study staff during the trial.
Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
Recruiting
This trial is looking for young people aged 12 to 19 who have a normal weight, are overweight, or have obesity and are at risk for type 2 diabetes. Participants will undergo brain scans and cognitive tests to help understand how weight and blood sugar levels affect brain health.
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Recruiting
This trial is looking for adults with type 2 diabetes who struggle to manage their condition. Participants will compare the effectiveness of a new drug, elecoglipron, with an existing treatment, semaglutide.
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Recruiting
This trial is looking for children and teenagers with type 2 diabetes. Participants will receive either a new medicine called CagriSema or a placebo for part of the study, and then everyone will receive CagriSema for the second part.
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Recruiting
This trial is looking for adults with type 2 diabetes, high blood pressure, and heart disease. Participants will take either the study medication or a placebo daily for up to 4 years.
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Recruiting
This trial is looking for adults with type 2 diabetes who want to try a new medicine called survodutide to help control their blood sugar levels. Participants will receive either the medicine or a placebo and will continue their usual diabetes treatments over about 14 months with regular check-ins.
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Recruiting
This trial is looking for young people ages 1 to 25 who have recently been diagnosed with stage 3 type 1 diabetes. Participants will receive either teplizumab or a placebo through an IV to see how it affects their blood sugar control over 52 weeks.
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Recruiting
This trial is looking for children and adults who are at high risk for type 1 diabetes, meaning they have certain markers in their blood that suggest they might develop the condition soon. To participate, you should be at least 18 pounds in weight and not have any other types of diabetes or serious heart-related issues. They also won't be able to include anyone who has had certain serious infections or health problems.
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Recruiting
This trial is looking for children and adults who have recently been diagnosed with type 1 diabetes, specifically within the last 100 days. To join, they need to still show some signs of their pancreas working. However, people with other types of diabetes, serious heart problems, or certain health risks can’t participate.
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Recruiting
This trial is looking for people with Type 1 diabetes who experience severe low blood sugar. Participants will receive an infusion of VX-880 and will need to use a continuous glucose monitor during the study.
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Recruiting
This trial is looking for adults with type 2 diabetes who are at high risk for heart problems. Participants will receive injections of either zenagamtide or insulin glargine once a week to see which works better for controlling blood sugar and weight.
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Recruiting
This trial is looking for children with Type 2 diabetes to test different doses of a medication called dulaglutide. Participation will last about 8 months and requires being treated with certain diabetes medications.
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
Recruiting
This trial is looking for people with Type 1 Diabetes who have had a kidney transplant. Participants will receive treatment with VX-880 and will need to use a continuous glucose monitor during the study.
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes
Recruiting
This trial is looking for pregnant women aged 18-40 who have gestational diabetes. Participants will try two types of insulin to see which one works better for controlling blood sugar after meals.
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Recruiting
This trial is looking for young people aged 9 to under 21 who have recently been diagnosed with Type 1 Diabetes. Participants will receive a treatment called anti-thymocyte globulin (ATG) followed by either adalimumab or verapamil to see how well it helps preserve insulin secretion over two years.
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Recruiting
This trial is looking for people aged 5 to 40 who have recently been diagnosed with Type 1 Diabetes. Participants will receive either the study medication or a placebo and will be monitored for safety and effectiveness.
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Recruiting
This trial is looking for adults with type 2 diabetes who have certain blood sugar levels and are managing their condition with specific injectable medications. They should also have maintained their weight for a few months and not have serious heart issues or other specific health conditions. However, it’s important that they haven’t recently used any weight loss medications or insulin.
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Recruiting
This trial is looking for people with type 2 diabetes to test a new medicine called UBT251. Participants will receive either UBT251, a placebo, or another medication called semaglutide, chosen at random.
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Recruiting
This trial is looking for adults who are at least 18 years old and have type 2 diabetes that isn’t well controlled. They should have been on stable diabetes medications for a while and show signs of high cortisol levels. However, it won't include anyone who just started having diabetes, has serious low blood sugar issues, or works night shifts regularly.
Where the Diabetes studies are in Pennsylvania
Research sites running the most studies
- University of Pittsburgh, Pittsburgh11 trials
- University of Pennsylvania, Philadelphia9 trials
- Thomas Jefferson University, Philadelphia5 trials
- Children's Hospital of Philadelphia, Philadelphia4 trials
- Heritage Valley Medical Group, Beaver4 trials
- Research Site, Philadelphia3 trials
By city
Counts are recruiting studies listing at least one site in Pennsylvania, from ClinicalTrials.gov, refreshed every two days.
Diabetes clinical trials in Pennsylvania: common questions
How many Diabetes clinical trials are recruiting in Pennsylvania?
TrialFinder currently lists 80 recruiting Diabetes clinical trials with study sites in Pennsylvania. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Diabetes clinical trials located in Pennsylvania?
Study sites for the Diabetes trials listed on this page include Reading, Pittsburgh, Philadelphia. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Diabetes clinical trial in Pennsylvania?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Diabetes trials in Pennsylvania also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Diabetes clinical trial in Pennsylvania?
Each study sets its own criteria based on age, Diabetes diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Can I join a diabetes clinical trial if I am already on medication?
Usually yes. Most type 2 diabetes trials enroll people on metformin or other oral medicines and test a new treatment on top of them; some require a stable dose for a few months first. Trials that exclude insulin or a specific drug say so in their criteria.
Do I need to know my A1c to apply?
No. Trials state an A1c range, but the study site measures it at the screening visit. You only need to know that you have been diagnosed and which type.
Diabetes Trials in Other States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Helpful Reading
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
All guides →
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
Check Your Eligibility
Create a free profile and our AI will match you to Diabetes trials near you in Pennsylvania.
Get Matched — FreeNo insurance required
About Diabetes Trials
Diabetes clinical trials study new treatments for Type 1, Type 2, and gestational diabetes, including insulin therapies, diet interventions, and islet-cell transplants.
All Diabetes trials →Other Conditions in Pennsylvania
Cancer
Breast Cancer
Depression
Anxiety
Alzheimer's
Heart Disease
Asthma
Multiple Sclerosis
Obesity
Parkinson's
Lupus
Hypertension
COPD
Stroke
Arthritis
Kidney Disease
COVID-19